Correlation Between Salesforce and Vivoryon Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and Vivoryon Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and Vivoryon Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and Vivoryon Therapeutics NV, you can compare the effects of market volatilities on Salesforce and Vivoryon Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of Vivoryon Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and Vivoryon Therapeutics.

Diversification Opportunities for Salesforce and Vivoryon Therapeutics

-0.08
  Correlation Coefficient

Good diversification

The 3 months correlation between Salesforce and Vivoryon is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and Vivoryon Therapeutics NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivoryon Therapeutics and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with Vivoryon Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivoryon Therapeutics has no effect on the direction of Salesforce i.e., Salesforce and Vivoryon Therapeutics go up and down completely randomly.

Pair Corralation between Salesforce and Vivoryon Therapeutics

Considering the 90-day investment horizon Salesforce is expected to generate 1.33 times more return on investment than Vivoryon Therapeutics. However, Salesforce is 1.33 times more volatile than Vivoryon Therapeutics NV. It trades about 0.23 of its potential returns per unit of risk. Vivoryon Therapeutics NV is currently generating about -0.47 per unit of risk. If you would invest  29,640  in Salesforce on August 31, 2024 and sell it today you would earn a total of  3,361  from holding Salesforce or generate 11.34% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy95.65%
ValuesDaily Returns

Salesforce  vs.  Vivoryon Therapeutics NV

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
Vivoryon Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vivoryon Therapeutics NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vivoryon Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Salesforce and Vivoryon Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and Vivoryon Therapeutics

The main advantage of trading using opposite Salesforce and Vivoryon Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, Vivoryon Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivoryon Therapeutics will offset losses from the drop in Vivoryon Therapeutics' long position.
The idea behind Salesforce and Vivoryon Therapeutics NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world